Showing results (21-30 of 5,917) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|August 24, 2015
Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonographyMayumi Shimizu, Kazutoshi Okamura, Yoshitaka Kise, et al.
Arthritis Research & Therapy|August 14, 2015
Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisLuisa Lindenberg, Lydia Spengler, Holger Bang, et al.
Arthritis Research & Therapy|July 29, 2015
Blockade of bone morphogenetic protein signaling potentiates the pro-inflammatory phenotype induced by interleukin-17 and tumor necrosis factor-α combination in rheumatoid synoviocytesAlberto Varas, Jaris Valencia, Fabien Lavocat, et al.
Arthritis Research & Therapy|July 29, 2015
The effects of joint aspiration and intra-articular corticosteroid injection on flexion reflex excitability, quadriceps strength and pain in individuals with knee synovitis: a prospective observational studyDavid Andrew Rice, Peter John McNair, Gwyn Nancy Lewis, et al.
Arthritis Research & Therapy|August 21, 2015
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trialsWilliam Stohl, Joan T Merrill, R John Looney, et al.
Arthritis Research & Therapy|April 28, 2016
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendationsLeslie R Harrold, George W Reed, Joel M Kremer, et al.
Arthritis Research & Therapy|April 23, 2016
Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitisÅsa Cm Johansson, Sophie Ohlsson, Åsa Pettersson, et al.
Arthritis Research & Therapy|April 23, 2016
Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective studyBobby Kwanghoon Han, Igor Kuzin, John P Gaughan, et al.
Arthritis Research & Therapy|March 13, 2016
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progressionTue Wenzel Kragstrup, Stinne Ravn Greisen, Morten Aagaard Nielsen, et al.
Arthritis Research & Therapy|July 4, 2013
Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndromeSusan Lester, Leanne Stokes, Kristen K Skarratt, et al.
Pageof 592